Liu X, Zhang Q, Guo H, Pan Q, Zhou K. Bendamustine, gemcitabine, and vinorelbine (BeGEV) regimen followed by ASCT induces durable remissions in PD-(L)1 inhibitor-resistant refractory/relapsed classical Hodgkin lymphoma: a single-center, long-term study. Blood. 2025;146(suppl 1):1847.

Blood 2026 Open access

Read full text

DOI: 10.1182/blood.2025032948

Cited by: 0

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research CAR-T cell therapy research